Metraipolis › archive › dc_b43e57be4da0

Digitally-enhanced medication-assisted treatment for opioid use disorder: acceptability, engagement and treatment retention — Europe PMC PMID:41113189

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41113189
DOI
10.3389/fpsyt.2025.1581298
License (as archived)
solo-consultazione
Archived
2026-11-09T14:53:25.266Z
SHA-256 of the archived text
ed481fdc6722ada5f4b1d8260e41ce0ad294a9df74d67d814744344249d8f41e
Stable URL of this page
https://metraipolis.com/documento/dc_b43e57be4da0

How to cite

Digitally-enhanced medication-assisted treatment for opioid use disorder: acceptability, engagement and treatment retention — Europe PMC PMID:41113189 — Europe PMC (en), https://europepmc.org/article/MED/41113189 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b43e57be4da0 (Metraipolis archive dc_b43e57be4da0, sha256 ed481fdc6722ada5f4b1d8260e41ce0ad294a9df74d67d814744344249d8f41e)
BibTeX
@misc{dcb43e57be4da0,
  title = {Digitally-enhanced medication-assisted treatment for opioid use disorder: acceptability, engagement and treatment retention — Europe PMC PMID:41113189},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41113189},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b43e57be4da0; sha256 ed481fdc6722ada5f4b1d8260e41ce0ad294a9df74d67d814744344249d8f41e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41113189. Agents can read the archived copy with the MCP tool read_document.